This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Le Marchand, L. Articles by Wang, H. Search for Related Content PubMed PubMed Citation Articles by Le Marchand, L. Articles by Wang, H.

Smokers with the CHRNA Lung Cancer–Associated Variants Are Exposed to Higher Levels of Nicotine Equivalents and a Carcinogenic Tobacco-Specific Nitrosamine

¹ Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii and ² Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota

Requests for reprints: Loïc Le Marchand, Epidemiology Program, Cancer Research Center of Hawaii, University of Hawaii, 1236 Lauhala Street, Suite 407, Honolulu, HI 96813. Phone: 808-586-2988; Fax: 808-586-2082; E-mail: loic{at}crch.hawaii.edu.

Key Words: Genetic variation • Lung Cancer • Smoking

A locus at 15q24/15q25.1, which includes the nicotinic acetylcholine receptor A subunits 3 and 5 (CHRNA3 and CHRNA5) genes, has recently been associated with lung cancer risk, self-reported number of cigarettes smoked per day, and a nicotine dependence scale. It is not clear whether the association with lung cancer is direct or mediated through differences in smoking behavior. We used urinary biomarkers to test whether two linked lung cancer risk variants in CHRNA3 (rs1051730) and CHRNA5 (rs16969968) are associated with intensity of smoking and exposure to a tobacco-specific carcinogenic nitrosamine per cigarette dose. We studied 819 smokers and found that carriers of these variants extract a greater amount of nicotine (P = 0.003) and are exposed to a higher internal dose of 4-(methylnitrosamino)-I-(3-pyridyl)-1-butanone (P = 0.03) per cigarette than noncarriers. Thus, smokers who carry the CHRNA3 and CHRNA5 variants are expected to be at increased risk for lung cancer compared with smokers who do not carry these alleles even if they smoked the same number of cigarettes. Number of cigarettes per day, even if it could be accurately assessed, is not an adequate measure of smoking dose. [Cancer Res 2008;68(22):9137–40]

This article has been cited by other articles:

				E. H Lips, V. Gaborieau, J. D McKay, A. Chabrier, R. J Hung, P. Boffetta, M. Hashibe, D. Zaridze, N. Szeszenia-Dabrowska, J. Lissowska, et al. Association between a 15q25 gene variant, smoking quantity and tobacco-related cancers among 17 000 individuals Int. J. Epidemiol., September 23, 2009; (2009) dyp288v1. [Abstract] [Full Text] [PDF]

				S. Zienolddiny, V. Skaug, N. E. Landvik, D. Ryberg, D. H. Phillips, R. Houlston, and A. Haugen The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung Carcinogenesis, August 1, 2009; 30(8): 1368 - 1371. [Abstract] [Full Text] [PDF]